4//SEC Filing
Gray Nancy Ryan 4
Accession 0000886163-20-000077
CIK 0000886163other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 6:34 PM ET
Size
7.1 KB
Accession
0000886163-20-000077
Insider Transaction Report
Form 4
Gray Nancy Ryan
Director
Transactions
- Award
Common Stock
2020-06-10+831→ 3,072 total - Award
Non-Qualified Stock Option (right to buy)
2020-06-10+2,468→ 2,468 totalExercise: $117.58Exp: 2030-06-10→ Common Stock (2,468 underlying)
Footnotes (2)
- [F1]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001714949
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 6:34 PM ET
- Size
- 7.1 KB